Spinal Tech

Zyga Technology presented publication on the first 50 patients in its EVoluSIon clinical study. The 250 patient at 40 site study is evaluating long-term fusion and pain reduction in patients that undergo procedures using the SImmentry Sacroiliac Joint Fusion System.

Medovex converted its FDA Investigational Device Exemption submission to a pre-submission.

In 2009, The New England Journal of Medicine published two studies, the INVEST and Australian trials, that cast doubt on the benefits of vertebral augmentation.1,2 The analyses found no significant differences in pain relief between vertebroplasty and a sham intervention. These…

New developments do not only improve patient satisfaction, but can also improve surgeon satisfaction. Anthony Zannis, director of upstream marketing at Mizuho OSI, explains how technology can improve patient outcomes as well as what patients and surgeons can expect from…

Here are three key notes on orthopedic and spine device companies from the past week.

The hiatus on the medical device excise tax is set to expire Dec. 31 and device makers are lobbying the White House to prevent the tax from taking effect, Forbes reports.

Hartford (Conn.) HealthCare installed the Globus ExcelsiusGPS, a surgical guidance system.

Life Spine said several physicians have successfully used its Simpact Tri-Fin Sacroiliac Joint Fusion System.

The FDA cleared 23 spine-related devices in November.

Here are 12 key notes on orthopedic and spine device companies from the past week.